All News

"Alvin David, B.S.N., RN-BC, wrote this exemplar as part of his promotion to clinical nurse 3. I will let his words do the talking, as they reveal his true essence as a nurse, colleague, preceptor, friend, father, husband and extraordinary healer," wrote Margie McDonald, M.S.N., RN, CBCN of Memorial Sloan Kettering Monmouth.

With no available diagnostic tests for the detection and/or monitoring of bladder cancer, researchers from the Medical College of Georgia at Augusta University may have two new urine tests that determine the disease’s severity and detect for its recurrence.

Art is a creative outlet that provides health benefits to those affected by cancer. Art therapy is becoming more widely used in the field of medicine as its ability to help people is evidenced.

One expert discusses the significance of newer drugs and the role they play in helping patients with relapsed or refractory disease.

From the first annual Glioblastoma Awareness Day to politics and today’s top performers, here’s what’s making headlines in the cancer space this week.​

We've got a sneak peek at what’s inside CURE®'s lung cancer special issue.

A small molecule drug may help to overcome resistance to Imbruvica in patients with MCL, according to preclinical study findings from The University of Texas MD Anderson Cancer Center.

May is recognized as Bladder Cancer Awareness Month. Know the facts and statistics in order to understand your risk for the disease and take preventative actions to guard your health.

A diagnosis of cancer is completely overwhelming and something most of us are not prepared for. It may be easy to think about giving up before treatment starts. Instead, here are five things that helped me push through.

The Food and Drug Administration has approved the combination use of Venclexta plus Gazyva for the frontline treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

A recent study showed that postmenopausal women demonstrated a significant reduction in the risk for bladder cancer after quitting smoking, highlighting the need for prevention and cessation programs in older women.

The combination use of Abraxane plus gemcitabine and cisplatin for the treatment of advanced biliary tract cancers prolonged survival, according to phase 2 study findings.

The Food and Drug Administration’s Oncologic Drugs Advisory Committee voted against approving a new drug application for quizartinib for adult patients with relapsed/refractory FLT3-ITD–positive AML.

Sometimes it doesn't pay to make comparisons.

The Food and Drug Administration approved the combination use of Bavencio plus Inlyta for the first-line treatment of patients with advanced renal cell carcinoma.

Carrying chronic illness can be very difficult, but there are ways to navigate the world without being crushed by the weight of what we cannot control.

The FDA’s Oncologic Drugs Advisory Committee voted in favor of the agency approving pexidartinib to treat adult patients with symptomatic tenosynovial giant cell tumor – a rare, benign lesion that can be locally aggressive and often recurring.

Researchers at Baylor College of Medicine found that a particular subgroup of patients with advanced bladder cancer, identified with a computational tool, responded to immunotherapy.

I hear friends talk about feeling old and resisting the natural process of aging. “Old” for me was a dream and a wish. Now I rejoice in every wrinkle as affirmation that I am getting older. Yahoo. I can’t wait to be 70.

A call to action—We all need to do our part to combat fake or inaccurate health news. Misinformation about any health topic is troubling and potentially dangerous.

Children diagnosed with embryonal brain tumors who have experienced treatment-related hearing loss exhibited greater difficulties reading – in particular, with phonological skills and processing speed, according to study results.

The V Foundation for Cancer Research and ESPN Hall of Fame Sportscaster Dick Vitale are pleased to announce the 14th Annual Dick Vitale Gala raised more than $4.3 million for pediatric cancer research.

A good nurse can make a huge difference for a patient struggling to deal with an illness, not only in comfort, or pain relief, or even in teaching how to manage symptoms or side effects – but in hope and confidence.

The Prostate Cancer Foundation announced the newly revised 2019 Prostate Cancer Patient Guide, a comprehensive resource for diagnosis, treatment, side effects, survivorship, and risk factors for patients and families with a history of prostate cancer.

“‘Compassionate,’ “cheerleader,’ ‘friend’ ‘supporter’ and ‘angel’ are just a few words used by patients and staff to describe Harding Cranford, RN, OCN,” wrote Erin Auten, RN.

A breast cancer survivor remembers an inconvenient Mother’s Day phone call as he celebrates five years of being cancer-free.

The Food and Drug Administration approved Cyramza for certain patients with hepatocellular carcinoma.

Survivors find that physical activity and sound nutrition lower health risks and boost well-being.

From National Women's Health Week to today’s top athletes, here’s what’s making headlines in the cancer space this week.

With the growing price of cancer treatment, researchers evaluated the cost-effectiveness of the new standard-of-care in frontline metastatic renal cell carcinoma.